| 1 | 1521904 | Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis. | Int J Artif Organs | 1992 Mar |
1 |
| 2 | 1560570 | [Effect of nafamostat mesilate on the renin-aldosterone system]. | Masui | 1992 Mar |
1 |
| 3 | 1768503 | Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column. | ASAIO Trans | 1991 Oct-Dec |
1 |
| 4 | 1861238 | Improvement in wound healing by epidermal growth factor (EGF) ointment. II. Effect of protease inhibitor, nafamostat, on stabilization and efficacy of EGF in burn. | J Pharmacobiodyn | 1991 Jan |
1 |
| 5 | 1989498 | The enzymatic activity of human cytotoxic T-lymphocyte granzyme A and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175. | Arch Biochem Biophys | 1991 Jan |
1 |
| 6 | 2050602 | Consumption coagulopathy associated with left atrial thrombosis. | Hematol Pathol | 1991 |
2 |
| 7 | 2128896 | Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF. | Pharm Res | 1990 Dec |
3 |
| 8 | 2435641 | [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro]. | Nihon Yakurigaku Zasshi | 1986 Dec |
3 |
| 9 | 2739065 | [The effect of the protease inhibitor FUT-175 on phospholipase A2, complement, prostaglandins and prekallikrein during endotoxin shock]. | Masui | 1989 Mar |
2 |
| 10 | 6086386 | Detection of intermediary Clr with complete active site, using a synthetic proteinase inhibitor. | FEBS Lett | 1984 Jul 9 |
2 |
| 11 | 6215361 | Inhibition of various immunological reactions in vivo by a new synthetic complement inhibitor. | Int Arch Allergy Appl Immunol | 1982 |
4 |
| 12 | 6618346 | [Immunopharmacological actions of 6-amidino-2-naphthyl-4-guanidinobenzoate (FUT-175). 1. Effect of FUT-175 on immune response and host defense in mice]. | Nihon Yakurigaku Zasshi | 1983 Jun |
1 |
| 13 | 7620820 | Inhibitory effect of FUT-175 on the production of interleukin 8 and polymorphonuclear leukocyte elastase. | Res Commun Mol Pathol Pharmacol | 1995 Mar |
2 |
| 14 | 7763192 | Effect of nafamostat mesilate on bradykinin generation and hemodynamics during LDL apheresis. | Artif Organs | 1995 Feb |
1 |
| 15 | 7816751 | Effect of epidermal growth factor on Cu, Zn-superoxide dismutase expression in cultured fibroblasts from rat skin. | Pharm Res | 1994 Sep |
1 |
| 16 | 7836734 | Angiotensin II formation by an alternative pathway during exercise in humans. | J Hypertens | 1994 Oct |
2 |
| 17 | 7959424 | [Effects of E3123 on pancreatic injury in the isolated, perfused rat pancreas and in a pancreatic slice]. | Nihon Yakurigaku Zasshi | 1994 Oct |
2 |
| 18 | 8029816 | Effect of nafamostat mesilate, a synthetic protease inhibitor, on tissue factor-factor VIIa complex activity. | Thromb Res | 1994 Apr 15 |
1 |
| 19 | 8312873 | Cytoprotective effects of epidermal growth factor (EGF) ointment containing nafamostat, a protease inhibitor, on tissue damage at burn sites in rats. | Biol Pharm Bull | 1993 Nov |
4 |
| 20 | 9032217 | Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats. | Am J Respir Crit Care Med | 1997 Feb |
1 |
| 21 | 9127328 | Active inhibitory effect of nafamostat mesylate against the elevation of plasma myeloperoxidase during hemodialysis. | Nephron | 1997 |
3 |
| 22 | 9128326 | Preoperative transcatheter arterial embolization for giant cavernous hemangioma of the liver with consumption coagulopathy. | Am J Gastroenterol | 1997 Apr |
1 |
| 23 | 10066865 | Prevention of neointimal formation by a serine protease inhibitor, FUT-175, after carotid balloon injury in rats. | Stroke | 1999 Mar |
1 |
| 24 | 10430784 | Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation. | Clin Chem | 1999 Aug |
5 |
| 25 | 10440571 | FUT-175 inhibits the production of IL-6 and IL-8 in human monocytes. | Res Commun Mol Pathol Pharmacol | 1999 Jan |
4 |
| 26 | 10655909 | A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate. | Br J Anaesth | 1999 Sep |
1 |
| 27 | 10954057 | Nafamostat mesilate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apoptosis in cultured human trophoblasts. | Life Sci | 2000 |
2 |
| 28 | 11294265 | Extracorporeal membrane oxygenation for newborns with gastric rupture. | Pediatr Surg Int | 2001 |
1 |
| 29 | 11958287 | Plasma levels of myeloperoxidase and elastase are differentially regulated by hemodialysis membranes and anticoagulants. | Res Commun Mol Pathol Pharmacol | 2000 Nov-Dec |
1 |
| 30 | 12203894 | Two-dimensional analysis of myocardial protein expression following myocardial ischemia and reperfusion in rabbits. | Proteomics | 2002 Aug |
1 |
| 31 | 12506133 | Inhibition of prostasin secretion by serine protease inhibitors in the kidney. | J Am Soc Nephrol | 2003 Jan |
2 |
| 32 | 12592100 | Induction of IkappaB-kinase by cholecystokinin is mediated by trypsinogen activation in rat pancreatic lobules. | Digestion | 2002 |
1 |
| 33 | 12642398 | A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. | Br J Pharmacol | 2003 Mar |
4 |
| 34 | 12744489 | Serine proteases are involved in the pathogenesis of trauma-hemorrhagic shock-induced gut and lung injury. | Shock | 2003 May |
1 |
| 35 | 12890431 | Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages. | Int Immunopharmacol | 2003 Sep |
5 |
| 36 | 15655299 | Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase/PAR-2 in vascular endothelial barrier function. | J Pharmacol Sci | 2005 Jan |
1 |
| 37 | 15894839 | A serine protease inhibitor, nafamostat mesilate, suppresses aldosterone secretions in vivo. | Hypertens Res | 2004 Dec |
1 |
| 38 | 16093612 | Nafamostat mesilate induces production of interleukin-12 and -18 in human peripheral blood mononuclear cells. | J Pharmacol Sci | 2005 Aug |
6 |
| 39 | 16260585 | Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice. | J Leukoc Biol | 2005 Nov |
1 |
| 40 | 16359660 | Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. | Eur J Pharmacol | 2006 Jan 13 |
4 |
| 41 | 16552341 | Intracellular activation of trypsinogen in rat pancreatic acini after supramaximal secretagogue stimulation: cysteine protease and serine protease activity. | Pancreas | 2006 Mar |
1 |
| 42 | 16612309 | Nafamostat attenuated the impairment of fibrinolysis in animal sepsis model by suppressing the increase of plasminogen activator inhibitor type 1. | J Trauma | 2006 Apr |
1 |
| 43 | 16702735 | Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis. | Drug Metab Pharmacokinet | 2006 Apr |
1 |
| 44 | 16801094 | Inhibitory mechanism of human platelet aggregation by nafamostat mesilate. | Platelets | 1999 Jul |
2 |
| 45 | 16815145 | Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. | J Allergy Clin Immunol | 2006 Jul |
1 |
| 46 | 17414427 | Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7. | Shock | 2007 Apr |
1 |
| 47 | 17458645 | Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. | J Anesth | 2007 |
1 |
| 48 | 17624024 | Nafamostat is hydrolysed by human liver cytosolic long-chain acyl-CoA hydrolase. | Xenobiotica | 2007 Mar |
1 |
| 49 | 18602161 | Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. | Mol Immunol | 2008 Aug |
2 |
| 50 | 19008643 | Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma. | J Pharmacol Sci | 2008 Nov |
3 |